A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Study of the Safety and Efficacy of LX3305, a Sphingosine-1-Phosphate Lyase Inhibitor, for Treatment of Darier’s Disease or Hailey-Hailey Disease - DERM-101
100 Clinical Results associated with Dermecular Therapeutics, Inc.
0 Patents (Medical) associated with Dermecular Therapeutics, Inc.
100 Deals associated with Dermecular Therapeutics, Inc.
100 Translational Medicine associated with Dermecular Therapeutics, Inc.